| 2026-08-20 | Federal Register | Federal Register notice: Advisory Committee; Endocrinologic and Metabolic Drugs Advisory Committee; Renewal | Regulator Federal Register |
| 2026-07-14 | Trial | New trial registered: Determination of Resistance Training Status for Patients on Glucagon-Like Peptide-1 Receptor Agonists | Trial register ClinicalTrials.gov |
| 2026-05-27 | Label | FDA label revised: Exenatide (ANDA206697) | Regulator FDA drug label register |
| 2026-03-27 | Trial | New trial registered: Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis | Trial register ClinicalTrials.gov |
| 2026-03-09 | Federal Register | Federal Register notice: Aspen Global Inc. c/o Lachman Consultant Services, Inc., et al.; Withdrawal of Approval of 46 New Drug Applications | Regulator Federal Register |
| 2026-01-16 | Trial | New trial registered: A Single-Center, Open-Label, Single Ascending Dose Study of Exenatide Circular RNA-Lipid Nanoparticle Injection (CR059) in Chinese Subjects With Typ | Trial register ClinicalTrials.gov |
| 2026-01-06 | Trial | New trial registered: Clinical Study of 18F-Exendin-4 in Insulinoma | Trial register ClinicalTrials.gov |
| 2025-12-30 | Trial | New trial registered: Clinical, Morphometric and Biochemical Effects on Adiposopathy Associated With the Use of GLP-1RA in CKD | Trial register ClinicalTrials.gov |
| 2025-11-21 | Results | Results posted: Comparison of Type 2 Diabetes Pharmacotherapy Regimens | Trial register ClinicalTrials.gov |
| 2025-10-02 | Federal Register | Federal Register notice: Pediatric Advisory Committee (PAC); Notice of Meeting; Establishment of a Public Docket; Request for Comments | Regulator Federal Register |
| 2025-09-16 | Trial | New trial registered: Using Secondary Data to Evaluate Sex-based Heterogeneity of GLP-1 Agonists and SGLT2 Inhibitors on Cardiovascular-Kidney-Metabolic Health (CKMH) Out | Trial register ClinicalTrials.gov |
| 2025-09-02 | Label | FDA label revised: Byetta (NDA021773) | Regulator FDA drug label register |
| 2025-08-04 | Federal Register | Federal Register notice: Teva Branded Pharmaceutical Products R&D, Inc., et al.; Withdrawal of Approval of 39 New Drug Applications | Regulator Federal Register |
| 2025-07-01 | Results | Results posted: Pharmacogenomics of GLP1 Receptor Agonists | Trial register ClinicalTrials.gov |
| 2025-06-27 | Results | Results posted: Exenatide Once-weekly as a Treatment for Multiple System Atrophy | Trial register ClinicalTrials.gov |
| 2025-03-10 | Trial | New trial registered: Food (Poly)Phenol Metabotypes and Beta-cell Mass and Function. | Trial register ClinicalTrials.gov |
| 2024-12-10 | Trial | New trial registered: Glucagon-like Peptide-1 Receptor PET/CT in GLP-1R Related Disease | Trial register ClinicalTrials.gov |
| 2024-09-05 | Results | Results posted: Durability of Combination Therapy With Exenatide/Pioglitazone/Metformin vs. Conventional Therapy in New Onset T2DM | Trial register ClinicalTrials.gov |
| 2024-08-23 | Federal Register | Federal Register notice: Final Decision on the Proposal To Refuse To Approve a New Drug Application for ITCA 650 | Regulator Federal Register |
| 2024-06-07 | Trial | New trial registered: Real-World Evaluation of Omarigliptin for Type 2 Diabetes Meliitus in Bangladesh | Trial register ClinicalTrials.gov |
| 2024-06-04 | Results | Results posted: Liver and Fat Regulation in Overweight Adolescent Girls | Trial register ClinicalTrials.gov |
| 2024-04-24 | Results | Results posted: A Trial to Determine the Efficacy and Safety of Presendin in IIH | Trial register ClinicalTrials.gov |
| 2024-04-16 | Results | Results posted: GLP-1 Receptor Agonist Therapy and Albuminuria in Patients With Type 2 Diabetes | Trial register ClinicalTrials.gov |
| 2024-02-29 | Results | Results posted: An Investigation Into the Effect of Dapagliflozin on Ketogenesis in Type 1 Diabetes | Trial register ClinicalTrials.gov |
| 2024-02-14 | Trial | New trial registered: A Phase 3 Study to Evaluate the Efficacy of JY09 Compared With Dulaglutide in Combination Therapy Diabetes Mellitus Type 2 Patients With Metformin | Trial register ClinicalTrials.gov |
| 2024-02-13 | Trial | New trial registered: Association of Gene Polymorphism With Susceptibility to T2DM and the Therapeutic Responses to Exenatide in Chinese Patients With T2DM | Trial register ClinicalTrials.gov |
| 2024-02-12 | Trial | New trial registered: Exenatide For Reducing the Reinforcing Effects of Cocaine | Trial register ClinicalTrials.gov |
| 2024-02-03 | Trial | New trial registered: A Phase 3 Study to Evaluate the Efficacy of JY09 Compared With Placebo in T2DM Patients | Trial register ClinicalTrials.gov |
| 2024-01-22 | Trial | New trial registered: Influence of JY09 on Pharmacokinetics of Metformin , Rosuvastatin , and Digoxin and the QT Interval Study in Overweight Chinese Subjects | Trial register ClinicalTrials.gov |
| 2023-12-29 | Results | Results posted: FLuctuATion Reduction With inSULin and Glp-1 Added togetheR (FLAT-SUGAR) | Trial register ClinicalTrials.gov |
| 2023-12-04 | Results | Results posted: The Effect of GLP-1 Agonists Versus OCs on Reproductive Disorders and Cardiovascular Risks in Overweight PCOS | Trial register ClinicalTrials.gov |
| 2023-08-24 | Federal Register | Federal Register notice: Endocrinologic and Metabolic Drugs Advisory Committee; Notice of Alternative Form of Hearing | Regulator Federal Register |
| 2023-08-24 | Federal Register | Federal Register notice: Endocrinologic and Metabolic Drugs Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments | Regulator Federal Register |
| 2023-07-24 | Results | Results posted: Can Exenatide Prevent Increase in EGP in Response to Dapagliflozin-induced Increase in Glucosuria | Trial register ClinicalTrials.gov |
| 2023-07-20 | Results | Results posted: Effect of Chronic Exenatide Therapy on Beta Cell Function and Insulin Sensitivity in T2DM | Trial register ClinicalTrials.gov |
| 2023-05-17 | Results | Results posted: Extended Release Exenatide Versus Placebo In Diabetic Patients With Type 4 Cardiorenal Syndrome | Trial register ClinicalTrials.gov |
| 2023-03-10 | Trial | New trial registered: Pharmacogenomics of GLP1 Receptor Agonists | Trial register ClinicalTrials.gov |
| 2023-01-04 | Trial | New trial registered: Assessment of Safety, Tolerability and Drug Levels of Exenatide Implant | Trial register ClinicalTrials.gov |
| 2022-12-23 | Trial | New trial registered: A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Th | Trial register ClinicalTrials.gov |
| 2022-12-01 | Trial | New trial registered: Assessment of Pancreatic Beta Cell Mass and Function by Positron Emission Tomography Imaging in Human Diabetes Mellitus | Trial register ClinicalTrials.gov |
| 2022-11-09 | Trial | New trial registered: Exenatide for Smoking Cessation and Prevention of Weight Gain | Trial register ClinicalTrials.gov |
| 2022-11-08 | Trial | New trial registered: BetaFIT Study: Beta Cell Imaging After Faecal mIcrobiota Transplantation | Trial register ClinicalTrials.gov |
| 2022-10-28 | Results | Results posted: Assess the Efficacy and Safety of Exenatide SR for the Prevention of Diabetes After Kidney Transplantation | Trial register ClinicalTrials.gov |
| 2022-10-06 | Results | Results posted: Exeantide in Type 2 Diabetes on Insulin | Trial register ClinicalTrials.gov |
| 2022-08-01 | Trial | New trial registered: Exenatide Pharmacokinetics and Pharmacodynamics in Gestational Diabetes | Trial register ClinicalTrials.gov |
| 2022-06-27 | Results | Results posted: Exenatide for Treating Cocaine Use Disorder | Trial register ClinicalTrials.gov |
| 2022-06-02 | Trial | New trial registered: Exendin PET/CT for Imaging of Paragangliomas | Trial register ClinicalTrials.gov |
| 2022-05-20 | Federal Register | Federal Register notice: Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability | Regulator Federal Register |
| 2022-05-05 | Results | Results posted: Energy Balance & Weight Loss in Craniopharyngioma-related or Other Hypothalamic Tumors in Hypothalamic Obesity | Trial register ClinicalTrials.gov |
| 2022-04-20 | Trial | New trial registered: A Trial to Determine the Efficacy and Safety of Presendin in IIH | Trial register ClinicalTrials.gov |
| 2022-04-14 | Trial | New trial registered: Study to Evaluate the Pharmacokinetic Characteristics of Pegylated Exenatide Injection (PB-119) in Subjects With Different Degrees of Renal Insuffic | Trial register ClinicalTrials.gov |
| 2022-04-08 | Trial | New trial registered: GLP-1 Analogue in Preventing Progression of Small Vessel Disease (GAPP-SVD) | Trial register ClinicalTrials.gov |
| 2022-02-09 | Results | Results posted: The Effects of Exenatide, a GLP-1 Agonist, on Alcohol Self-Administration in Heavy Drinkers | Trial register ClinicalTrials.gov |
| 2022-01-21 | Results | Results posted: Intravenous Exenatide (Byetta) During Surgery | Trial register ClinicalTrials.gov |
| 2022-01-03 | Results | Results posted: Enhancing Weight Loss Maintenance With GLP-1RA (BYDUREON™) in Adolescents With Severe Obesity | Trial register ClinicalTrials.gov |
| 2021-12-22 | Trial | New trial registered: Comparative Effectiveness and Safety of Four Second Line Pharmacological Strategies in Type 2 Diabetes Study | Trial register ClinicalTrials.gov |
| 2021-11-29 | Trial | New trial registered: SEMAGLUTIDE VERSUS GLP-1 RECEPTOR AGONISTS. EFFECTIVENESS , SAFETY AND QUALITY OF LIFE IN PATIENTS WITH DIABETES MELLITUS 2. OBSERVATIONAL, PROSPECT | Trial register ClinicalTrials.gov |
| 2021-11-23 | Trial | New trial registered: BESTMED: Observational Evaluation of Second Line Therapy Medications in Diabetes | Trial register ClinicalTrials.gov |
| 2021-10-11 | Trial | New trial registered: Comparison of Type 2 Diabetes Pharmacotherapy Regimens | Trial register ClinicalTrials.gov |
| 2021-09-02 | Federal Register | Federal Register notice: Proposal To Refuse To Approve a New Drug Application for ITCA 650 (Exenatide in DUROS Device); Opportunity for a Hearing | Regulator Federal Register |
| 2021-09-02 | Trial | New trial registered: [68Ga]Ga-HBED-CC-exendin-4 and [68Ga]Ga-NOTA-exendin-4 PET/CT Imaging in the Same Group of Insulinoma Patients | Trial register ClinicalTrials.gov |
| 2021-08-04 | Results | Results posted: New Onset Type 1 Diabetes: Role of Exenatide | Trial register ClinicalTrials.gov |
| 2021-07-27 | Trial | New trial registered: The Clinical Application of 68Ga-NOTA-exendin-4 PET/CT in Detecting Insulinoma | Trial register ClinicalTrials.gov |
| 2021-07-21 | Trial | New trial registered: Effects of GLP-1 Analogue Combined With Metformin and Metformin on Gonadal and Metabolic Profiles in Chinese Overweight/Obese PCOS Patients With Hyp | Trial register ClinicalTrials.gov |
| 2021-06-28 | Trial | New trial registered: Exenatide for Treating Cocaine Use Disorder | Trial register ClinicalTrials.gov |
| 2021-06-15 | Results | Results posted: Exenatide Weekly Injections as an Adjunctive Treatment in Patients With Schizophrenia | Trial register ClinicalTrials.gov |
| 2021-06-01 | Trial | New trial registered: Exenatide-test for Diagnosing Endogenous Hyperinsulinemic Hypoglycemia | Trial register ClinicalTrials.gov |
| 2021-05-28 | Results | Results posted: Bexagliflozin Drug/Drug Interaction Study With Exenatide Injection | Trial register ClinicalTrials.gov |
| 2021-05-24 | Trial | New trial registered: Identification and Clinical Relevance of an Oxytocin Deficient State (GLP1 Study) | Trial register ClinicalTrials.gov |
| 2021-04-14 | Results | Results posted: A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes | Trial register ClinicalTrials.gov |
| 2021-04-06 | Results | Results posted: Islet Transplantation in Type 1 Diabetic Patients Using the University of Illinois at Chicago (UIC) Protocol | Trial register ClinicalTrials.gov |
| 2021-02-02 | Trial | New trial registered: Glucagon Like Peptide 1 Receptor (GLP1R) Expression and Beta-cell Mass in Patients With Type 2 Diabetes | Trial register ClinicalTrials.gov |
| 2021-01-29 | Results | Results posted: EQW, DAPA, EQW/DAPA, DAPA/MET ER and PHEN/TPM ER in Obese Women With PolycysticOvary Syndrome (PCOS) | Trial register ClinicalTrials.gov |
| 2021-01-28 | Results | Results posted: Exenatide Once Weekly for Smoking Cessation | Trial register ClinicalTrials.gov |
| 2020-12-03 | Results | Results posted: Safety and Efficacy Study of Exenatide Once Weekly in Adolescents With Type 2 Diabetes | Trial register ClinicalTrials.gov |
| 2020-12-01 | Results | Results posted: Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents With Type 2 Diabetes | Trial register ClinicalTrials.gov |
| 2020-10-22 | Trial | New trial registered: A GLP-1 Receptor PET Imaging Substudy Within the VER-A-T1D Trial Investigating the Effects on Beta Cell Mass | Trial register ClinicalTrials.gov |
| 2020-08-24 | Results | Results posted: A Study Comparing the Effect of Albiglutide With Exenatide on Regional Brain Activity Related to Nausea in Healthy Subjects | Trial register ClinicalTrials.gov |
| 2020-08-20 | Trial | New trial registered: Brain Activation and Satiety in Children 2 | Trial register ClinicalTrials.gov |
| 2020-08-05 | Trial | New trial registered: Safety and Efficacy of Pegylated Exenatine Injection (PB-119) in Drug-naïve T2DM Subjects | Trial register ClinicalTrials.gov |
| 2020-08-05 | Trial | New trial registered: Safety and Efficacy of PB-119 in Subjects With Type 2 Diabetes and Not Well-controlled by Metformin Monotherapy | Trial register ClinicalTrials.gov |
| 2020-06-16 | Trial | New trial registered: Exenatide Once-weekly as a Treatment for Multiple System Atrophy | Trial register ClinicalTrials.gov |
| 2020-04-02 | Trial | New trial registered: Proof of Concept Study in Patients With Short Bowel Syndrome | Trial register ClinicalTrials.gov |
| 2020-03-31 | Results | Results posted: Effects of Obesity Treatments on Food Preferences and Metabolism | Trial register ClinicalTrials.gov |
| 2020-03-13 | Trial | New trial registered: Effect of Glucagon and Glucagon-like Peptide-1 Co-agonism on Cardiac Function and Metabolism in Overweight Participants with Type 2 Diabetes | Trial register ClinicalTrials.gov |
| 2020-03-12 | Trial | New trial registered: Exenatide Treatment in Parkinson's Disease | Trial register ClinicalTrials.gov |
| 2020-03-11 | Trial | New trial registered: The Effect of Exenatide on Fasting Bile Acids | Trial register ClinicalTrials.gov |
| 2020-02-17 | Trial | New trial registered: SR-Exenatide (PT320) to Eveluate Efficacy and Safety in Patients With Early Parkinson's Disease | Trial register ClinicalTrials.gov |
| 2020-02-12 | Results | Results posted: Weight Loss With Exenatide Treatment | Trial register ClinicalTrials.gov |
| 2020-01-18 | Trial | New trial registered: Exenatide Once Weekly Over 2 Years as a Potential Disease Modifying Treatment for Parkinson's Disease | Trial register ClinicalTrials.gov |
| 2019-12-01 | Trial | New trial registered: Cardiovascular Outcomes SGLT-2 Inhibitors Versus GLP-1 Receptor Agonists | Trial register ClinicalTrials.gov |
| 2019-12-01 | Trial | New trial registered: Clinical Evaluation of 68Ga-NOTA-MAL-Cys39-exendin-4 Positron Emission Tomography in the Detection of Insulinoma | Trial register ClinicalTrials.gov |
| 2019-11-06 | Trial | New trial registered: A Study With NLY01 in Subjects With Type 2 Diabetes | Trial register ClinicalTrials.gov |
| 2019-11-04 | Trial | New trial registered: A Clinical Study of NLY01 in Patient's With Early Parkinson's Disease | Trial register ClinicalTrials.gov |
| 2019-10-22 | Results | Results posted: A Phase II Trial to Examine the Effect of Subcutaneous Exenatide (Bydureon®) on Glucose Control in Patients With Type I Diabetes | Trial register ClinicalTrials.gov |
| 2019-07-23 | Trial | New trial registered: Metformin vs Metformin Combined With GLP-1RA (Glucagon-like Peptide 1 Receptor Agonist) on Overweight/Obese PCOS Patients | Trial register ClinicalTrials.gov |
| 2019-07-11 | Trial | New trial registered: Evaluation of the Impact of Intensive Short-Term Drug Therapy in Patients With Type 2 Diabetes Mellitus | Trial register ClinicalTrials.gov |
| 2019-06-28 | Trial | New trial registered: Study of Exenatide Once-Weekly Suspension in Chinese Patients With Type 2 Diabetes Mellitus | Trial register ClinicalTrials.gov |
| 2019-06-20 | Results | Results posted: Exenatide Inpatient Trial: A Randomized Controlled Pilot Trial on the Safety and Efficacy of Exenatide (Byetta®) Therapy for the Inpatient Management of P | Trial register ClinicalTrials.gov |
| 2019-06-12 | Results | Results posted: Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC) Versus GLP-1 Receptor Agonist in Patients With Type 2 Diabetes, Wit | Trial register ClinicalTrials.gov |